The primary value of placebo controls in clinical trials is the minimization of bias.

"Unlike other MDMA-Assisted Therapy/Psychedelic Assisted Therapy long-term studies, this will be one of the first that I'm ...

Acumen Pharmaceuticals has concluded enrolment for the Phase II ALTITUDE-AD trial of sabirnetug for treating patients with ...

While all dogs cross the rainbow bridge, On Point Veterinary in Hamilton is hoping to keep them on Earth a bit longer through a unique study.

The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome ...

Fish oil supplements, delivering higher EPA doses, significantly reduced the number and procoagulant activity of ...

Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity” or "the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...